deltatrials
Completed PHASE3 INTERVENTIONAL 2-arm NCT00030771

Preoperative Chemoradiotherapy vs. Chemotherapy Alone in NSCLC Patients

Preoperative Chemoradiotherapy vs. Chemotherapy Alone in Non-small Cell Lung Cancer (NSCLC) Patients With Mediastinal Lymph Node Metastases (Stage IIIA, N2): A Randomized Prospective Phase III Trial

Sponsor: Swiss Cancer Institute

Conditions Lung Cancer
Interventions Chemotherapy Radiotherapy Surgery
Updated 15 times since 2017 Last updated: Jan 16, 2024 Started: Apr 4, 2001 Primary completion: Apr 9, 2014 Completion: Sep 15, 2023
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Lung Cancer and is currently completed. Swiss Cancer Institute leads this study, which shows 15 recorded versions since 2001 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

~Jan 2017 – ~Jul 2017 · 6 months · monthly snapshot~Jul 2017 – ~Jun 2018 · 11 months · monthly snapshot~Jun 2018 – ~Jun 2019 · 12 months · monthly snapshot~Jun 2019 – ~Jun 2020 · 12 months · monthly snapshot~Jun 2020 – ~Jan 2021 · 7 months · monthly snapshot~Jan 2021 – ~Sep 2021 · 8 months · monthly snapshot~Sep 2021 – ~Oct 2021 · 30 days · monthly snapshot~Oct 2021 – ~Jul 2022 · 9 months · monthly snapshot~Jul 2022 – ~Feb 2023 · 7 months · monthly snapshot~Feb 2023 – ~Feb 2024 · 12 months · monthly snapshot~Feb 2024 – ~Jul 2024 · 5 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Aug 2025 · 11 months · monthly snapshot~Aug 2025 – ~Sep 2025 · 31 days · monthly snapshot~Sep 2025 – present · 9 months · monthly snapshot

Change History

15 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed PHASE3

  2. Aug 2025 — Sep 2025 [monthly]

    Completed PHASE3

  3. Sep 2024 — Aug 2025 [monthly]

    Completed PHASE3

  4. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE3

  5. Feb 2024 — Jul 2024 [monthly]

    Completed PHASE3

    Status: Active Not Recruiting → Completed

▶ Show 10 earlier versions

  1. Feb 2023 — Feb 2024 [monthly]

    Active Not Recruiting PHASE3

  2. Jul 2022 — Feb 2023 [monthly]

    Active Not Recruiting PHASE3

  3. Oct 2021 — Jul 2022 [monthly]

    Active Not Recruiting PHASE3

  4. Sep 2021 — Oct 2021 [monthly]

    Active Not Recruiting PHASE3

  5. Jan 2021 — Sep 2021 [monthly]

    Active Not Recruiting PHASE3

  6. Jun 2020 — Jan 2021 [monthly]

    Active Not Recruiting PHASE3

  7. Jun 2019 — Jun 2020 [monthly]

    Active Not Recruiting PHASE3

  8. Jun 2018 — Jun 2019 [monthly]

    Active Not Recruiting PHASE3

  9. Jul 2017 — Jun 2018 [monthly]

    Active Not Recruiting PHASE3

  10. Jan 2017 — Jul 2017 [monthly]

    Active Not Recruiting PHASE3

    First recorded

Apr 2001

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Swiss Cancer Institute
Data source: Swiss Cancer Institute

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Aarau, Switzerland , Baden, Switzerland , Basel, Switzerland , Bellinzona, Switzerland , Bern, Switzerland , Bruderholz, Switzerland , Chur, Switzerland , Fribourg, Switzerland , Geneva, Switzerland , Kamenitz, Serbia and 10 more locations